Global Anti-obesity Drugs Market Research Report 2024, Forecast to 2032
Report Overview
Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.
The global Anti-obesity Drugs market size was estimated at USD 66890 million in 2023 and is projected to reach USD 93570.16 million by 2032, exhibiting a CAGR of 3.80% during the forecast period.
North America Anti-obesity Drugs market size was estimated at USD 18583.53 million in 2023, at a CAGR of 3.26% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Anti-obesity Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-obesity Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-obesity Drugs market in any manner.
Global Anti-obesity Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Market Segmentation (by Type)
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Market Segmentation (by Application)
Kids
Adults
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-obesity Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Anti-obesity Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.
The global Anti-obesity Drugs market size was estimated at USD 66890 million in 2023 and is projected to reach USD 93570.16 million by 2032, exhibiting a CAGR of 3.80% during the forecast period.
North America Anti-obesity Drugs market size was estimated at USD 18583.53 million in 2023, at a CAGR of 3.26% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Anti-obesity Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-obesity Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-obesity Drugs market in any manner.
Global Anti-obesity Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Market Segmentation (by Type)
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Market Segmentation (by Application)
Kids
Adults
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Anti-obesity Drugs Market
- Overview of the regional outlook of the Anti-obesity Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-obesity Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Anti-obesity Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Anti-obesity Drugs
1.2 Key Market Segments
1.2.1 Anti-obesity Drugs Segment by Type
1.2.2 Anti-obesity Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-OBESITY DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-obesity Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Anti-obesity Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-OBESITY DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-obesity Drugs Sales by Manufacturers (2019-2024)
3.2 Global Anti-obesity Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-obesity Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-obesity Drugs Sales Sites, Area Served, Product Type
3.6 Anti-obesity Drugs Market Competitive Situation and Trends
3.6.1 Anti-obesity Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-obesity Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-OBESITY DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Anti-obesity Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-OBESITY DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-OBESITY DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-obesity Drugs Sales Market Share by Type (2019-2024)
6.3 Global Anti-obesity Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Anti-obesity Drugs Price by Type (2019-2024)
7 ANTI-OBESITY DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-obesity Drugs Market Sales by Application (2019-2024)
7.3 Global Anti-obesity Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-obesity Drugs Sales Growth Rate by Application (2019-2024)
8 ANTI-OBESITY DRUGS MARKET CONSUMPTION BY REGION
8.1 Global Anti-obesity Drugs Sales by Region
8.1.1 Global Anti-obesity Drugs Sales by Region
8.1.2 Global Anti-obesity Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-obesity Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-obesity Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-obesity Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-obesity Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-obesity Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ANTI-OBESITY DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Anti-obesity Drugs by Region (2019-2024)
9.2 Global Anti-obesity Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Anti-obesity Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Anti-obesity Drugs Production
9.4.1 North America Anti-obesity Drugs Production Growth Rate (2019-2024)
9.4.2 North America Anti-obesity Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Anti-obesity Drugs Production
9.5.1 Europe Anti-obesity Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Anti-obesity Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Anti-obesity Drugs Production (2019-2024)
9.6.1 Japan Anti-obesity Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Anti-obesity Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Anti-obesity Drugs Production (2019-2024)
9.7.1 China Anti-obesity Drugs Production Growth Rate (2019-2024)
9.7.2 China Anti-obesity Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Anti-obesity Drugs Basic Information
10.1.2 Merck Anti-obesity Drugs Product Overview
10.1.3 Merck Anti-obesity Drugs Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck Anti-obesity Drugs SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Novo Nordisk
10.2.1 Novo Nordisk Anti-obesity Drugs Basic Information
10.2.2 Novo Nordisk Anti-obesity Drugs Product Overview
10.2.3 Novo Nordisk Anti-obesity Drugs Product Market Performance
10.2.4 Novo Nordisk Business Overview
10.2.5 Novo Nordisk Anti-obesity Drugs SWOT Analysis
10.2.6 Novo Nordisk Recent Developments
10.3 Pfizer
10.3.1 Pfizer Anti-obesity Drugs Basic Information
10.3.2 Pfizer Anti-obesity Drugs Product Overview
10.3.3 Pfizer Anti-obesity Drugs Product Market Performance
10.3.4 Pfizer Anti-obesity Drugs SWOT Analysis
10.3.5 Pfizer Business Overview
10.3.6 Pfizer Recent Developments
10.4 Arena Pharmaceuticals
10.4.1 Arena Pharmaceuticals Anti-obesity Drugs Basic Information
10.4.2 Arena Pharmaceuticals Anti-obesity Drugs Product Overview
10.4.3 Arena Pharmaceuticals Anti-obesity Drugs Product Market Performance
10.4.4 Arena Pharmaceuticals Business Overview
10.4.5 Arena Pharmaceuticals Recent Developments
10.5 Roche
10.5.1 Roche Anti-obesity Drugs Basic Information
10.5.2 Roche Anti-obesity Drugs Product Overview
10.5.3 Roche Anti-obesity Drugs Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Anti-obesity Drugs Basic Information
10.6.2 GlaxoSmithKline Anti-obesity Drugs Product Overview
10.6.3 GlaxoSmithKline Anti-obesity Drugs Product Market Performance
10.6.4 GlaxoSmithKline Business Overview
10.6.5 GlaxoSmithKline Recent Developments
10.7 Orexigen Therapeutics
10.7.1 Orexigen Therapeutics Anti-obesity Drugs Basic Information
10.7.2 Orexigen Therapeutics Anti-obesity Drugs Product Overview
10.7.3 Orexigen Therapeutics Anti-obesity Drugs Product Market Performance
10.7.4 Orexigen Therapeutics Business Overview
10.7.5 Orexigen Therapeutics Recent Developments
10.8 Vivus
10.8.1 Vivus Anti-obesity Drugs Basic Information
10.8.2 Vivus Anti-obesity Drugs Product Overview
10.8.3 Vivus Anti-obesity Drugs Product Market Performance
10.8.4 Vivus Business Overview
10.8.5 Vivus Recent Developments
10.9 Amylin
10.9.1 Amylin Anti-obesity Drugs Basic Information
10.9.2 Amylin Anti-obesity Drugs Product Overview
10.9.3 Amylin Anti-obesity Drugs Product Market Performance
10.9.4 Amylin Business Overview
10.9.5 Amylin Recent Developments
10.10 Alizyme
10.10.1 Alizyme Anti-obesity Drugs Basic Information
10.10.2 Alizyme Anti-obesity Drugs Product Overview
10.10.3 Alizyme Anti-obesity Drugs Product Market Performance
10.10.4 Alizyme Business Overview
10.10.5 Alizyme Recent Developments
10.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Anti-obesity Drugs Basic Information
10.11.2 Boehringer Ingelheim Anti-obesity Drugs Product Overview
10.11.3 Boehringer Ingelheim Anti-obesity Drugs Product Market Performance
10.11.4 Boehringer Ingelheim Business Overview
10.11.5 Boehringer Ingelheim Recent Developments
10.12 Eisai
10.12.1 Eisai Anti-obesity Drugs Basic Information
10.12.2 Eisai Anti-obesity Drugs Product Overview
10.12.3 Eisai Anti-obesity Drugs Product Market Performance
10.12.4 Eisai Business Overview
10.12.5 Eisai Recent Developments
11 ANTI-OBESITY DRUGS MARKET FORECAST BY REGION
11.1 Global Anti-obesity Drugs Market Size Forecast
11.2 Global Anti-obesity Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Anti-obesity Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Anti-obesity Drugs Market Size Forecast by Region
11.2.4 South America Anti-obesity Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Anti-obesity Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Anti-obesity Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Anti-obesity Drugs by Type (2025-2032)
12.1.2 Global Anti-obesity Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Anti-obesity Drugs by Type (2025-2032)
12.2 Global Anti-obesity Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Anti-obesity Drugs Sales (K MT) Forecast by Application
12.2.2 Global Anti-obesity Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Anti-obesity Drugs
1.2 Key Market Segments
1.2.1 Anti-obesity Drugs Segment by Type
1.2.2 Anti-obesity Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-OBESITY DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-obesity Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Anti-obesity Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-OBESITY DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-obesity Drugs Sales by Manufacturers (2019-2024)
3.2 Global Anti-obesity Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-obesity Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-obesity Drugs Sales Sites, Area Served, Product Type
3.6 Anti-obesity Drugs Market Competitive Situation and Trends
3.6.1 Anti-obesity Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-obesity Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-OBESITY DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Anti-obesity Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-OBESITY DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-OBESITY DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-obesity Drugs Sales Market Share by Type (2019-2024)
6.3 Global Anti-obesity Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Anti-obesity Drugs Price by Type (2019-2024)
7 ANTI-OBESITY DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-obesity Drugs Market Sales by Application (2019-2024)
7.3 Global Anti-obesity Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-obesity Drugs Sales Growth Rate by Application (2019-2024)
8 ANTI-OBESITY DRUGS MARKET CONSUMPTION BY REGION
8.1 Global Anti-obesity Drugs Sales by Region
8.1.1 Global Anti-obesity Drugs Sales by Region
8.1.2 Global Anti-obesity Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-obesity Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-obesity Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-obesity Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-obesity Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-obesity Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ANTI-OBESITY DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Anti-obesity Drugs by Region (2019-2024)
9.2 Global Anti-obesity Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Anti-obesity Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Anti-obesity Drugs Production
9.4.1 North America Anti-obesity Drugs Production Growth Rate (2019-2024)
9.4.2 North America Anti-obesity Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Anti-obesity Drugs Production
9.5.1 Europe Anti-obesity Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Anti-obesity Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Anti-obesity Drugs Production (2019-2024)
9.6.1 Japan Anti-obesity Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Anti-obesity Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Anti-obesity Drugs Production (2019-2024)
9.7.1 China Anti-obesity Drugs Production Growth Rate (2019-2024)
9.7.2 China Anti-obesity Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Anti-obesity Drugs Basic Information
10.1.2 Merck Anti-obesity Drugs Product Overview
10.1.3 Merck Anti-obesity Drugs Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck Anti-obesity Drugs SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Novo Nordisk
10.2.1 Novo Nordisk Anti-obesity Drugs Basic Information
10.2.2 Novo Nordisk Anti-obesity Drugs Product Overview
10.2.3 Novo Nordisk Anti-obesity Drugs Product Market Performance
10.2.4 Novo Nordisk Business Overview
10.2.5 Novo Nordisk Anti-obesity Drugs SWOT Analysis
10.2.6 Novo Nordisk Recent Developments
10.3 Pfizer
10.3.1 Pfizer Anti-obesity Drugs Basic Information
10.3.2 Pfizer Anti-obesity Drugs Product Overview
10.3.3 Pfizer Anti-obesity Drugs Product Market Performance
10.3.4 Pfizer Anti-obesity Drugs SWOT Analysis
10.3.5 Pfizer Business Overview
10.3.6 Pfizer Recent Developments
10.4 Arena Pharmaceuticals
10.4.1 Arena Pharmaceuticals Anti-obesity Drugs Basic Information
10.4.2 Arena Pharmaceuticals Anti-obesity Drugs Product Overview
10.4.3 Arena Pharmaceuticals Anti-obesity Drugs Product Market Performance
10.4.4 Arena Pharmaceuticals Business Overview
10.4.5 Arena Pharmaceuticals Recent Developments
10.5 Roche
10.5.1 Roche Anti-obesity Drugs Basic Information
10.5.2 Roche Anti-obesity Drugs Product Overview
10.5.3 Roche Anti-obesity Drugs Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Anti-obesity Drugs Basic Information
10.6.2 GlaxoSmithKline Anti-obesity Drugs Product Overview
10.6.3 GlaxoSmithKline Anti-obesity Drugs Product Market Performance
10.6.4 GlaxoSmithKline Business Overview
10.6.5 GlaxoSmithKline Recent Developments
10.7 Orexigen Therapeutics
10.7.1 Orexigen Therapeutics Anti-obesity Drugs Basic Information
10.7.2 Orexigen Therapeutics Anti-obesity Drugs Product Overview
10.7.3 Orexigen Therapeutics Anti-obesity Drugs Product Market Performance
10.7.4 Orexigen Therapeutics Business Overview
10.7.5 Orexigen Therapeutics Recent Developments
10.8 Vivus
10.8.1 Vivus Anti-obesity Drugs Basic Information
10.8.2 Vivus Anti-obesity Drugs Product Overview
10.8.3 Vivus Anti-obesity Drugs Product Market Performance
10.8.4 Vivus Business Overview
10.8.5 Vivus Recent Developments
10.9 Amylin
10.9.1 Amylin Anti-obesity Drugs Basic Information
10.9.2 Amylin Anti-obesity Drugs Product Overview
10.9.3 Amylin Anti-obesity Drugs Product Market Performance
10.9.4 Amylin Business Overview
10.9.5 Amylin Recent Developments
10.10 Alizyme
10.10.1 Alizyme Anti-obesity Drugs Basic Information
10.10.2 Alizyme Anti-obesity Drugs Product Overview
10.10.3 Alizyme Anti-obesity Drugs Product Market Performance
10.10.4 Alizyme Business Overview
10.10.5 Alizyme Recent Developments
10.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Anti-obesity Drugs Basic Information
10.11.2 Boehringer Ingelheim Anti-obesity Drugs Product Overview
10.11.3 Boehringer Ingelheim Anti-obesity Drugs Product Market Performance
10.11.4 Boehringer Ingelheim Business Overview
10.11.5 Boehringer Ingelheim Recent Developments
10.12 Eisai
10.12.1 Eisai Anti-obesity Drugs Basic Information
10.12.2 Eisai Anti-obesity Drugs Product Overview
10.12.3 Eisai Anti-obesity Drugs Product Market Performance
10.12.4 Eisai Business Overview
10.12.5 Eisai Recent Developments
11 ANTI-OBESITY DRUGS MARKET FORECAST BY REGION
11.1 Global Anti-obesity Drugs Market Size Forecast
11.2 Global Anti-obesity Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Anti-obesity Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Anti-obesity Drugs Market Size Forecast by Region
11.2.4 South America Anti-obesity Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Anti-obesity Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Anti-obesity Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Anti-obesity Drugs by Type (2025-2032)
12.1.2 Global Anti-obesity Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Anti-obesity Drugs by Type (2025-2032)
12.2 Global Anti-obesity Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Anti-obesity Drugs Sales (K MT) Forecast by Application
12.2.2 Global Anti-obesity Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-obesity Drugs Market Size Comparison by Region (M USD)
Table 5. Global Anti-obesity Drugs Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Anti-obesity Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-obesity Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-obesity Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-obesity Drugs as of 2022)
Table 10. Global Market Anti-obesity Drugs Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-obesity Drugs Sales Sites and Area Served
Table 12. Manufacturers Anti-obesity Drugs Product Type
Table 13. Global Anti-obesity Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-obesity Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-obesity Drugs Market Challenges
Table 22. Global Anti-obesity Drugs Sales by Type (K MT)
Table 23. Global Anti-obesity Drugs Market Size by Type (M USD)
Table 24. Global Anti-obesity Drugs Sales (K MT) by Type (2019-2024)
Table 25. Global Anti-obesity Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Anti-obesity Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-obesity Drugs Market Size Share by Type (2019-2024)
Table 28. Global Anti-obesity Drugs Price (USD/MT) by Type (2019-2024)
Table 29. Global Anti-obesity Drugs Sales (K MT) by Application
Table 30. Global Anti-obesity Drugs Market Size by Application
Table 31. Global Anti-obesity Drugs Sales by Application (2019-2024) & (K MT)
Table 32. Global Anti-obesity Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Anti-obesity Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-obesity Drugs Market Share by Application (2019-2024)
Table 35. Global Anti-obesity Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-obesity Drugs Sales by Region (2019-2024) & (K MT)
Table 37. Global Anti-obesity Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Anti-obesity Drugs Sales by Country (2019-2024) & (K MT)
Table 39. Europe Anti-obesity Drugs Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Anti-obesity Drugs Sales by Region (2019-2024) & (K MT)
Table 41. South America Anti-obesity Drugs Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Anti-obesity Drugs Sales by Region (2019-2024) & (K MT)
Table 43. Global Anti-obesity Drugs Production (K MT) by Region (2019-2024)
Table 44. Global Anti-obesity Drugs Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Anti-obesity Drugs Revenue Market Share by Region (2019-2024)
Table 46. Global Anti-obesity Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Anti-obesity Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Anti-obesity Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Anti-obesity Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Anti-obesity Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Merck Anti-obesity Drugs Basic Information
Table 52. Merck Anti-obesity Drugs Product Overview
Table 53. Merck Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Merck Business Overview
Table 55. Merck Anti-obesity Drugs SWOT Analysis
Table 56. Merck Recent Developments
Table 57. Novo Nordisk Anti-obesity Drugs Basic Information
Table 58. Novo Nordisk Anti-obesity Drugs Product Overview
Table 59. Novo Nordisk Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Novo Nordisk Business Overview
Table 61. Novo Nordisk Anti-obesity Drugs SWOT Analysis
Table 62. Novo Nordisk Recent Developments
Table 63. Pfizer Anti-obesity Drugs Basic Information
Table 64. Pfizer Anti-obesity Drugs Product Overview
Table 65. Pfizer Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Pfizer Anti-obesity Drugs SWOT Analysis
Table 67. Pfizer Business Overview
Table 68. Pfizer Recent Developments
Table 69. Arena Pharmaceuticals Anti-obesity Drugs Basic Information
Table 70. Arena Pharmaceuticals Anti-obesity Drugs Product Overview
Table 71. Arena Pharmaceuticals Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Arena Pharmaceuticals Business Overview
Table 73. Arena Pharmaceuticals Recent Developments
Table 74. Roche Anti-obesity Drugs Basic Information
Table 75. Roche Anti-obesity Drugs Product Overview
Table 76. Roche Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Roche Business Overview
Table 78. Roche Recent Developments
Table 79. GlaxoSmithKline Anti-obesity Drugs Basic Information
Table 80. GlaxoSmithKline Anti-obesity Drugs Product Overview
Table 81. GlaxoSmithKline Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Recent Developments
Table 84. Orexigen Therapeutics Anti-obesity Drugs Basic Information
Table 85. Orexigen Therapeutics Anti-obesity Drugs Product Overview
Table 86. Orexigen Therapeutics Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Orexigen Therapeutics Business Overview
Table 88. Orexigen Therapeutics Recent Developments
Table 89. Vivus Anti-obesity Drugs Basic Information
Table 90. Vivus Anti-obesity Drugs Product Overview
Table 91. Vivus Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Vivus Business Overview
Table 93. Vivus Recent Developments
Table 94. Amylin Anti-obesity Drugs Basic Information
Table 95. Amylin Anti-obesity Drugs Product Overview
Table 96. Amylin Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Amylin Business Overview
Table 98. Amylin Recent Developments
Table 99. Alizyme Anti-obesity Drugs Basic Information
Table 100. Alizyme Anti-obesity Drugs Product Overview
Table 101. Alizyme Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Alizyme Business Overview
Table 103. Alizyme Recent Developments
Table 104. Boehringer Ingelheim Anti-obesity Drugs Basic Information
Table 105. Boehringer Ingelheim Anti-obesity Drugs Product Overview
Table 106. Boehringer Ingelheim Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Boehringer Ingelheim Business Overview
Table 108. Boehringer Ingelheim Recent Developments
Table 109. Eisai Anti-obesity Drugs Basic Information
Table 110. Eisai Anti-obesity Drugs Product Overview
Table 111. Eisai Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Eisai Business Overview
Table 113. Eisai Recent Developments
Table 114. Global Anti-obesity Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 115. Global Anti-obesity Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Anti-obesity Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 117. North America Anti-obesity Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Anti-obesity Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 119. Europe Anti-obesity Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Anti-obesity Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 121. Asia Pacific Anti-obesity Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Anti-obesity Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 123. South America Anti-obesity Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Anti-obesity Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Anti-obesity Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Anti-obesity Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 127. Global Anti-obesity Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Anti-obesity Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 129. Global Anti-obesity Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 130. Global Anti-obesity Drugs Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-obesity Drugs Market Size Comparison by Region (M USD)
Table 5. Global Anti-obesity Drugs Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Anti-obesity Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-obesity Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-obesity Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-obesity Drugs as of 2022)
Table 10. Global Market Anti-obesity Drugs Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-obesity Drugs Sales Sites and Area Served
Table 12. Manufacturers Anti-obesity Drugs Product Type
Table 13. Global Anti-obesity Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-obesity Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-obesity Drugs Market Challenges
Table 22. Global Anti-obesity Drugs Sales by Type (K MT)
Table 23. Global Anti-obesity Drugs Market Size by Type (M USD)
Table 24. Global Anti-obesity Drugs Sales (K MT) by Type (2019-2024)
Table 25. Global Anti-obesity Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Anti-obesity Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-obesity Drugs Market Size Share by Type (2019-2024)
Table 28. Global Anti-obesity Drugs Price (USD/MT) by Type (2019-2024)
Table 29. Global Anti-obesity Drugs Sales (K MT) by Application
Table 30. Global Anti-obesity Drugs Market Size by Application
Table 31. Global Anti-obesity Drugs Sales by Application (2019-2024) & (K MT)
Table 32. Global Anti-obesity Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Anti-obesity Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-obesity Drugs Market Share by Application (2019-2024)
Table 35. Global Anti-obesity Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-obesity Drugs Sales by Region (2019-2024) & (K MT)
Table 37. Global Anti-obesity Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Anti-obesity Drugs Sales by Country (2019-2024) & (K MT)
Table 39. Europe Anti-obesity Drugs Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Anti-obesity Drugs Sales by Region (2019-2024) & (K MT)
Table 41. South America Anti-obesity Drugs Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Anti-obesity Drugs Sales by Region (2019-2024) & (K MT)
Table 43. Global Anti-obesity Drugs Production (K MT) by Region (2019-2024)
Table 44. Global Anti-obesity Drugs Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Anti-obesity Drugs Revenue Market Share by Region (2019-2024)
Table 46. Global Anti-obesity Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Anti-obesity Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Anti-obesity Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Anti-obesity Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Anti-obesity Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Merck Anti-obesity Drugs Basic Information
Table 52. Merck Anti-obesity Drugs Product Overview
Table 53. Merck Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Merck Business Overview
Table 55. Merck Anti-obesity Drugs SWOT Analysis
Table 56. Merck Recent Developments
Table 57. Novo Nordisk Anti-obesity Drugs Basic Information
Table 58. Novo Nordisk Anti-obesity Drugs Product Overview
Table 59. Novo Nordisk Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Novo Nordisk Business Overview
Table 61. Novo Nordisk Anti-obesity Drugs SWOT Analysis
Table 62. Novo Nordisk Recent Developments
Table 63. Pfizer Anti-obesity Drugs Basic Information
Table 64. Pfizer Anti-obesity Drugs Product Overview
Table 65. Pfizer Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Pfizer Anti-obesity Drugs SWOT Analysis
Table 67. Pfizer Business Overview
Table 68. Pfizer Recent Developments
Table 69. Arena Pharmaceuticals Anti-obesity Drugs Basic Information
Table 70. Arena Pharmaceuticals Anti-obesity Drugs Product Overview
Table 71. Arena Pharmaceuticals Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Arena Pharmaceuticals Business Overview
Table 73. Arena Pharmaceuticals Recent Developments
Table 74. Roche Anti-obesity Drugs Basic Information
Table 75. Roche Anti-obesity Drugs Product Overview
Table 76. Roche Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Roche Business Overview
Table 78. Roche Recent Developments
Table 79. GlaxoSmithKline Anti-obesity Drugs Basic Information
Table 80. GlaxoSmithKline Anti-obesity Drugs Product Overview
Table 81. GlaxoSmithKline Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Recent Developments
Table 84. Orexigen Therapeutics Anti-obesity Drugs Basic Information
Table 85. Orexigen Therapeutics Anti-obesity Drugs Product Overview
Table 86. Orexigen Therapeutics Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Orexigen Therapeutics Business Overview
Table 88. Orexigen Therapeutics Recent Developments
Table 89. Vivus Anti-obesity Drugs Basic Information
Table 90. Vivus Anti-obesity Drugs Product Overview
Table 91. Vivus Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Vivus Business Overview
Table 93. Vivus Recent Developments
Table 94. Amylin Anti-obesity Drugs Basic Information
Table 95. Amylin Anti-obesity Drugs Product Overview
Table 96. Amylin Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Amylin Business Overview
Table 98. Amylin Recent Developments
Table 99. Alizyme Anti-obesity Drugs Basic Information
Table 100. Alizyme Anti-obesity Drugs Product Overview
Table 101. Alizyme Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Alizyme Business Overview
Table 103. Alizyme Recent Developments
Table 104. Boehringer Ingelheim Anti-obesity Drugs Basic Information
Table 105. Boehringer Ingelheim Anti-obesity Drugs Product Overview
Table 106. Boehringer Ingelheim Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Boehringer Ingelheim Business Overview
Table 108. Boehringer Ingelheim Recent Developments
Table 109. Eisai Anti-obesity Drugs Basic Information
Table 110. Eisai Anti-obesity Drugs Product Overview
Table 111. Eisai Anti-obesity Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Eisai Business Overview
Table 113. Eisai Recent Developments
Table 114. Global Anti-obesity Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 115. Global Anti-obesity Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Anti-obesity Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 117. North America Anti-obesity Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Anti-obesity Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 119. Europe Anti-obesity Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Anti-obesity Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 121. Asia Pacific Anti-obesity Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Anti-obesity Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 123. South America Anti-obesity Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Anti-obesity Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Anti-obesity Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Anti-obesity Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 127. Global Anti-obesity Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Anti-obesity Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 129. Global Anti-obesity Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 130. Global Anti-obesity Drugs Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Anti-obesity Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-obesity Drugs Market Size (M USD), 2019-2032
Figure 5. Global Anti-obesity Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Anti-obesity Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-obesity Drugs Market Size by Country (M USD)
Figure 11. Anti-obesity Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Anti-obesity Drugs Revenue Share by Manufacturers in 2023
Figure 13. Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-obesity Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-obesity Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-obesity Drugs Market Share by Type
Figure 18. Sales Market Share of Anti-obesity Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Anti-obesity Drugs by Type in 2023
Figure 20. Market Size Share of Anti-obesity Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-obesity Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-obesity Drugs Market Share by Application
Figure 24. Global Anti-obesity Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-obesity Drugs Sales Market Share by Application in 2023
Figure 26. Global Anti-obesity Drugs Market Share by Application (2019-2024)
Figure 27. Global Anti-obesity Drugs Market Share by Application in 2023
Figure 28. Global Anti-obesity Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-obesity Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Anti-obesity Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Anti-obesity Drugs Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-obesity Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Anti-obesity Drugs Sales Market Share by Country in 2023
Figure 37. Germany Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Anti-obesity Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Anti-obesity Drugs Sales Market Share by Region in 2023
Figure 44. China Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Anti-obesity Drugs Sales and Growth Rate (K MT)
Figure 50. South America Anti-obesity Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Anti-obesity Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Anti-obesity Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Anti-obesity Drugs Production Market Share by Region (2019-2024)
Figure 62. North America Anti-obesity Drugs Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Anti-obesity Drugs Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Anti-obesity Drugs Production (K MT) Growth Rate (2019-2024)
Figure 65. China Anti-obesity Drugs Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Anti-obesity Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Anti-obesity Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Anti-obesity Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Anti-obesity Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Anti-obesity Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Anti-obesity Drugs Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Anti-obesity Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-obesity Drugs Market Size (M USD), 2019-2032
Figure 5. Global Anti-obesity Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Anti-obesity Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-obesity Drugs Market Size by Country (M USD)
Figure 11. Anti-obesity Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Anti-obesity Drugs Revenue Share by Manufacturers in 2023
Figure 13. Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-obesity Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-obesity Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-obesity Drugs Market Share by Type
Figure 18. Sales Market Share of Anti-obesity Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Anti-obesity Drugs by Type in 2023
Figure 20. Market Size Share of Anti-obesity Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-obesity Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-obesity Drugs Market Share by Application
Figure 24. Global Anti-obesity Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-obesity Drugs Sales Market Share by Application in 2023
Figure 26. Global Anti-obesity Drugs Market Share by Application (2019-2024)
Figure 27. Global Anti-obesity Drugs Market Share by Application in 2023
Figure 28. Global Anti-obesity Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-obesity Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Anti-obesity Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Anti-obesity Drugs Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-obesity Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Anti-obesity Drugs Sales Market Share by Country in 2023
Figure 37. Germany Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Anti-obesity Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Anti-obesity Drugs Sales Market Share by Region in 2023
Figure 44. China Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Anti-obesity Drugs Sales and Growth Rate (K MT)
Figure 50. South America Anti-obesity Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Anti-obesity Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Anti-obesity Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Anti-obesity Drugs Production Market Share by Region (2019-2024)
Figure 62. North America Anti-obesity Drugs Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Anti-obesity Drugs Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Anti-obesity Drugs Production (K MT) Growth Rate (2019-2024)
Figure 65. China Anti-obesity Drugs Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Anti-obesity Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Anti-obesity Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Anti-obesity Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Anti-obesity Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Anti-obesity Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Anti-obesity Drugs Market Share Forecast by Application (2025-2032)
